It is a cascade that worsens year after year, and taking melatonin pills does nothing to address the underlying structural problem
Number of cycles A cycle is a defined treatment period with a protocol length that varies by peptide: CJC/Ipamorelin and Tesamorelin run 12-week (3-month) cycles, the Wolverine Stack (BPC-157/TB-500) runs on a 3-months-on, 2-months-off schedule, and GHK-Cu runs 30-day cycles
Similarly, another clinical trial tested the effect of Glutathione on skin color and other related skin conditions, and the study showed positive results on the potential of Glutathione in the above-stated field
Conservative combination protocol (if attempting) Rationale for conservative approach: No safety data available Both peptides slow gastric emptying significantly Risk of severe GI complications Start low, go slow principle Tirzepatide component: Follow standard FDA-approved titration Weeks 1-4: 2.5mg weekly Weeks 5-8: 5mg weekly Weeks 9-12: 7.5mg weekly Weeks 13-16: 10mg weekly Week 17+: 12.5mg weekly (or stay at 10mg) Some reach 15mg weekly (maximum) Cagrilintide component (reduced from standard): Start AFTER tirzepatide stabilized at therapeutic dose (week 13+) Week 13-16: 0.6mg weekly (lower than standard) Week 17-20: 1.2mg weekly Week 21-24: 1.8mg weekly (may be maximum tolerable) Consider 2.4mg only if tolerating perfectly Conservative dosing comparison: Why sequential is safer: Tirzepatide establishes baseline first Can attribute new side effects to cagrilintide Easier to manage one variable at a time Option to stop cagrilintide if intolerable Less overwhelming than both simultaneously Expected benefits: 18-25% total weight loss (conservative estimate) Potentially superior to tirzepatide alone (15-22%) But incremental benefit may be modest (3-5% additional) Use SeekPeptides to plan sequential peptide additions safely
Every product at Tsujimoto Market is sourced directly from Japan and verified for authenticity
Frequently Asked Questions about IV Drip Therapy How long do the results of a skin whitening IV last
